000			01887 a2200505 4500
005			20250515002120.0
264		0	_c20051222
008			200512s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/j.bcp.2005.08.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aAbu-Bakar, A'edah
245	0	0	_aEvidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. _h[electronic resource]
260			_bBiochemical pharmacology _cNov 2005
300			_a1527-35 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAryl Hydrocarbon Hydroxylases _xantagonists & inhibitors
650	0	4	_aBilirubin _xchemistry
650	0	4	_aCadmium Chloride _xadministration & dosage
650	0	4	_aCytochrome P-450 CYP2A6
650	0	4	_aCytochrome P-450 Enzyme Inhibitors
650	0	4	_aCytochrome P-450 Enzyme System _xmetabolism
650	0	4	_aCytochrome P450 Family 2
650	0	4	_aHeme Oxygenase-1 _xbiosynthesis
650	0	4	_aInactivation, Metabolic _xgenetics
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aLiver _xchemistry
650	0	4	_aMale
650	0	4	_aMembrane Proteins _xgenetics
650	0	4	_aMice
650	0	4	_aMice, Inbred DBA
650	0	4	_aMicrosomes, Liver _xchemistry
650	0	4	_aMixed Function Oxygenases _xantagonists & inhibitors
650	0	4	_aOxazines _xantagonists & inhibitors
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aOxidoreductases _xantagonists & inhibitors
650	0	4	_aRNA, Messenger
650	0	4	_aTime Factors
650	0	4	_aUp-Regulation _xdrug effects
700	1		_aMoore, Michael R
700	1		_aLang, Matti A
773	0		_tBiochemical pharmacology _gvol. 70 _gno. 10 _gp. 1527-35
856	4	0	_uhttps://doi.org/10.1016/j.bcp.2005.08.009 _zAvailable from publisher's website
999			_c15814723 _d15814723